Sudden cardiac arrest and sudden cardiac death on dialysis: Epidemiology, evaluation, treatment, and prevention

Area of Science:

• Nephrology
• Cardiology
• Clinical Medicine

Background:

• Sudden cardiac death (SCD) is the leading cause of mortality in patients undergoing dialysis.
• SCD in this population is typically preceded by life-threatening arrhythmias like ventricular tachycardia or fibrillation.
• Several risk factors contribute to the high incidence of sudden cardiac arrest (SCA) and SCD in dialysis patients.

Purpose of the Study:

• To review primary and secondary prevention strategies for sudden cardiac arrest and sudden cardiac death in dialysis patients.
• To discuss the role of pharmacotherapy and implantable cardioverter defibrillators (ICDs) in managing these risks.
• To highlight the challenges and outcomes associated with ICD use in the dialysis population.

Main Methods:

• Review of existing literature on risk factors and prevention of sudden cardiac death in dialysis patients.
• Analysis of pharmacologic interventions including beta-blockers, ACE inhibitors, and ARBs.
• Evaluation of the role and efficacy of implantable cardioverter defibrillators (ICDs) for primary and secondary prevention.

Main Results:

• Primary prevention of SCA/SCD may involve avoiding low-potassium dialysate.
• Pharmacotherapy (beta-blockers, ACE inhibitors, ARBs) and ICDs are potential preventive measures for high-risk patients.
• While ICD indications are similar to non-dialysis patients, survival rates post-implantation are significantly lower in dialysis patients.

Conclusions:

• Dialysis patients face a high risk of sudden cardiac death, necessitating targeted preventive strategies.
• Pharmacotherapy and ICDs offer therapeutic options, but careful patient selection is crucial.
• The reduced survival rates following ICD implantation underscore the complex interplay between dialysis and cardiac health.